Sergei M. Gryaznov - 27 Jul 2022 Form 3 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role: Chief Scientific Officer
Signature: /s/ Sergei M. Gryaznov
Issuer symbol: MAIA
Transactions as of: 27 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 27 Jul 2022, 18:36:27 UTC
Next filing: 02 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MAIA	Common Stock						21,511	27 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	200,000	$1.80	Direct	F2
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	58,000	$1.80	Direct	F3
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	54,000	$1.80	Direct	F4
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	236,493	$1.80	Direct	F5
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	23,695	$1.80	Direct	F6
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	164,662	$1.83	Direct	F7
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	78,413	$1.83	Direct	F8
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	23,078	$1.83	Direct	F9
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	50,000	$1.83	Direct	F10
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	7,529	$1.83	Direct	F11

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Gryaznov beneficially owns 21,511 shares of common stock.
F2	Represents an option to purchase shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options fully vested on .December 1, 2019.
F3	Represents an option to purchase shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options vested in four equal monthly installments on December 1, 2019.
F4	Represents an option to purchase shares of Common Stock granted pursuant to the 2018 Stock Option Plan. 6,055 of these options vested on April 30, 2020 and 47,945 of these options vested on January 1, 2021.
F5	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on November 3, 2020.
F6	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 90 equal daily instalments beginning on January 1, 2021.
F7	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on May 20, 2021.
F8	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on May 20, 2021.
F9	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 90 equal daily instalments beginning on April 2, 2021.
F10	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 36 equal monthly instalments beginning on January 1, 2021.
F11	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options fully vested on July 1, 2021.